| Announcements |
-
2017-02-24 TaiwanJ completed enrollment for chronic liver disease (CLD) trial
TaiwanJ’s Phase II trial on JKB-122 for CLD therapy successfully reached the target enrollment in January 2017. After receiving the approval of its IND filing from the FDA/TFDA in 2014 Q1, Taiwa... -
2017-01-12 TaiwanJ attained the enrollment milestone in NASH trial
With the completion of subject recruitment in mid December, 2016, TaiwanJ Pharmaceuticals recently announced that its Phase II trial on JKB-121 for nonalcoholic steatohepatitis (NASH) therapy successf... -
2016-11-15 TaiwanJ Pharmaceuticals Highlights Presentation at the AASLD's 2016 Liver Mee...
TaiwanJ Pharmaceuticals Co., Ltd., a pharmaceutical company focused on discovery to clinical-stage development of novel treatments for liver and inflammatory diseases, announced that it woul... -
2016-07-11 TaiwanJ will join 2016 BioTaiwan Exhibition
TaiwanJ will join 2016 BioTaiwan Exhibition. Our exhibit venue is at Taipei World Trade Center- Nangang Exhibition Hall 4F. You will receive a gift for joining TaiwanJ Facebook’s Fan Page at exh... -
2015-10-06 TaiwanJ Pharmaceuticals Gains FDA Approval for Entering Phase 2 Clinical Stud...
TaiwanJ Pharmaceuticals announced that the US Food and Drug Administration (FDA) had approved its IND application for the Phase 2 clinical trial of JKB-122, a TLR4 (Toll-like Receptor 4) antagonist, o... -
2014-10-01 TaiwanJ Pharmaceuticals makes its debut at 2014 BIO International Convention
TaiwanJ Pharmaceuticals joined forces with the representatives from Taiwanese R&D Institutions, government agencies, and private biotech companies to showcase their latest innovations and drug dev... -
2014-07-01 TaiwanJ was granted status as a quality enterprise in「2014 Taiwan Healthcare...
TaiwanJ was granted status as a quality enterprise in「2014 Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Awards」. -
2014-04-01 MOEA granted TaiwanJ, in the second screening process, the status of Quality ...
MOEA granted TaiwanJ, in the second screening process, the status of Quality Project Sources 2014 for Industry Accelerating Incubation Plans. -
2013-11-02 Key members of Drug Discovery & Development team at BDL, ITRI joined the corp...
Key members of Drug Discovery & Development team at BDL, ITRI joined the corporate management team. -
2013-11-01 MOEA granted TaiwanJ, in the initial screening process, the status of Quality...
MOEA granted TaiwanJ, in the initial screening process, the status of Quality Project Sources 2013 for Industry Accelerating Incubation Plans.
